162 related articles for article (PubMed ID: 17506947)
1. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Cao LQ; Chen XL; Wang Q; Huang XH; Zhen MC; Zhang LJ; Li W; Bi J
Acta Pharmacol Sin; 2007 Jun; 28(6):879-87. PubMed ID: 17506947
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
Zhang W; Wu N; Li Z; Wang L; Jin J; Zha XL
Cancer Biol Ther; 2006 Aug; 5(8):1008-14. PubMed ID: 16775433
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone enhances 5-fluorouracil-induced cell growth inhibition in hepatocellular carcinoma cell line Hep3B.
Cao LQ; Shao ZL; Peng HP; Xiao JB; Xia T
Chin J Cancer; 2010 Aug; 29(8):741-6. PubMed ID: 20663321
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway.
Cao LQ; Wang XL; Wang Q; Xue P; Jiao XY; Peng HP; Lu HW; Zheng Q; Chen XL; Huang XH; Fu XH; Chen JS
Acta Pharmacol Sin; 2009 Sep; 30(9):1316-22. PubMed ID: 19684609
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
Han S; Roman J
Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells.
Lee SY; Kang EJ; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; In KH; Kang KH; Yoo SH; Shim JJ
Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L84-90. PubMed ID: 16443643
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.
Lin CF; Young KC; Bai CH; Yu BC; Ma CT; Chien YC; Chiang CL; Liao CS; Lai HW; Tsao CW
Biomed Res Int; 2014; 2014():787924. PubMed ID: 24757676
[TBL] [Abstract][Full Text] [Related]
10. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL
Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.
Schwab M; Reynders V; Loitsch S; Shastri YM; Steinhilber D; Schröder O; Stein J
Carcinogenesis; 2008 Jul; 29(7):1407-14. PubMed ID: 18544567
[TBL] [Abstract][Full Text] [Related]
13. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.
Teresi RE; Shaiu CW; Chen CS; Chatterjee VK; Waite KA; Eng C
Int J Cancer; 2006 May; 118(10):2390-8. PubMed ID: 16425225
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase and tensin homolog deleted on chromosome 10 suppression is an important process in peroxisome proliferator-activated receptor-gamma signaling in adipocytes and myotubes.
Kim KY; Cho HS; Jung WH; Kim SS; Cheon HG
Mol Pharmacol; 2007 Jun; 71(6):1554-62. PubMed ID: 17337625
[TBL] [Abstract][Full Text] [Related]
15. ONTD induces growth arrest and apoptosis of human hepatoma Bel-7402 cells though a peroxisome proliferator-activated receptor γ-dependent pathway.
Tan J; Shen W; Shi W; Chen X; Sun D; Xu C; Yan Q; Cheng H; Lai Y; Ji H
Toxicol In Vitro; 2017 Dec; 45(Pt 1):44-53. PubMed ID: 28834734
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone upregulates PTEN expression and induces the apoptosis of pulmonary artery smooth muscle cells under hypoxic conditions.
Pi WF; Guo XJ; Su LP; Xu WG
Int J Mol Med; 2013 Nov; 32(5):1101-9. PubMed ID: 24026200
[TBL] [Abstract][Full Text] [Related]
17. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells.
Kim KY; Kim SS; Cheon HG
Biochem Pharmacol; 2006 Aug; 72(5):530-40. PubMed ID: 16806087
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Shen B; Chu ES; Zhao G; Man K; Wu CW; Cheng JT; Li G; Nie Y; Lo CM; Teoh N; Farrell GC; Sung JJ; Yu J
Br J Cancer; 2012 Apr; 106(9):1486-94. PubMed ID: 22472882
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression.
Lee SY; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Lung Cancer; 2006 Mar; 51(3):297-301. PubMed ID: 16386327
[TBL] [Abstract][Full Text] [Related]
20. Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.
Jagan I; Fatehullah A; Deevi RK; Bingham V; Campbell FC
Oncogene; 2013 Mar; 32(10):1305-15. PubMed ID: 22543585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
